Phase I Study of the Combination of Afatinib and Ruxolitinib in Patients With Treatment-refractory Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT02145637 · COMPLETED
Trial details
- NCT number
- NCT02145637
- Sponsor
- Yonsei University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-07
- Primary completion
- 2017-11-09
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.